FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 10 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 10 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 5 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 20 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 50 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 1.5 ug/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-6084 | 71286-6084-1 | Glycopyrrolate | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | .1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | .1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | .5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-3020 | 71286-3020-1 | Ketamine Hydrochloride | 50 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 10 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Central Admixture Pharmacy Services, Inc.(154626886)" | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 20 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Compound Preferred, LLC(014579844)" | Methylcobalamin | 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .2 g/1 g; .06 g/1 g; .04 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .2 g/1 g; .06 g/1 g; .04 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Bevacizumab | 1.25 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Bevacizumab | 1.25 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Bevacizumab | 1.25 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 20 mg/1 g; 100 mg/1 g; 40 mg/1 g; 100 mg/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Procaine Hydrochloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Procaine Hydrochloride | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Brolucizumab | 6 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Brolucizumab | 6 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride | 5 mg/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Dexpanthenol | 250 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Dyclonine Hydrochloride; Lidocaine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Aflibercept | 2 mg/.05 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 100 mg/1 g; 40 mg/1 g; 100 mg/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine; Tetracaine | .23 g/1 g; .07 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine; Tetracaine | .23 g/1 g; .07 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-015 | 71449-015-06 | Atropine Sulfate | .4 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-022 | 71449-022-32 | Morphine Sulfate | 5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 |